1 National Institute for Health Research (NIHR) Birmingham, Liver Biomedical Research Unit, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK Primary sclerosing ...

Andy Obst ’90 and his wife, Mary Anne, don’t have your standard evening wind-down chats. That’s understandable given the work they share: inventing and manufacturing medical devices to treat ...

potentially caused by recurrent biliary infections. Distinguishing between a thrombus and tumor thrombus was challenging. After multidisciplinary discussion, surgery was deemed the optimal treatment.

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Primary biliary cholangitis (PBC) is an autoimmune disorder that leads to the destruction of bile ducts within the liver. As more bile ducts become lost and damaged, bile acids build up within the ...

The addition of multiparametric MRI to standard of care was cost-effective and enhanced diagnosis rates among patients with suspected metabolic dysfunction-associated liver disease, according to ...

Consensus dictates that AEF/graft enteric fistula (GEF), pseudoaneurysm at the site of anastomosis, rupture, and anastomosis dehiscence are contraindications for this approach. There are no ...

Tongyoo et al. developed a predictive model for DLC incorporating five clinical parameters (age >50 years, male sex, history of biliary inflammation, obesity, prior abdominal surgery) and four ...

The primary end point of overall response rate has been met in the COMPANION-002 trial of tovecimig and paclitaxel in advanced biliary tract cancer. In patients with advanced biliary tract cancer who ...

Biliary tract cancer occurs in the bile ducts and gallbladder, with approximately 23,000 diagnoses in the US each year. Life expectancy is poor, with just 5% to 15% of patients expected to live ...